1. Collagen biology and non‐invasive biomarkers of liver fibrosis. (19th February 2020) Authors: Karsdal, Morten A.; Daniels, Samuel J.; Holm Nielsen, Signe; Bager, Cecilie; Rasmussen, Daniel G.K.; Loomba, Rohit; Surabattula, Rambabu; Villesen, Ida Falk; Luo, Yi; Shevell, Diane; Gudmann, Natasja S.; Nielsen, Mette J.; George, Jacob; Christian, Rose; Leeming, Diana J.; Schuppan, Detlef Journal: Liver international Issue: Volume 40:Number 4(2020) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial. Issue 10165 (22nd December 2018) Authors: Sanyal, Arun; Charles, Edgar D; Neuschwander-Tetri, Brent A; Loomba, Rohit; Harrison, Stephen A; Abdelmalek, Manal F; Lawitz, Eric J; Halegoua-DeMarzio, Dina; Kundu, Sudeep; Noviello, Stephanie; Luo, Yi; Christian, Rose Journal: Lancet Issue: Volume 392:Issue 10165(2018) Page Start: 2705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study. Issue 1 (6th December 2018) Authors: Charles, Edgar D.; Neuschwander‐Tetri, Brent A.; Pablo Frias, Juan; Kundu, Sudeep; Luo, Yi; Tirucherai, Giridhar S.; Christian, Rose Journal: Obesity Issue: Volume 27:Issue 1(2019) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗